SkinHealth Systems stockholders elect nine directors, ratify Deloitte, approve executive compensation

The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent, registered public accounting firm for the fiscal year ending December 31, 2026, as follows: Votes For Votes Against Abstentions Broker Non-Votes 93,125,701 235,673 45,540 0

The Company’s stockholders elected the nine directors listed below, each to serve for a term of one year, expiring at the Company's 2027 annual meeting of stockholders or until his or her successor is duly appointed or elected and qualified or until his or her earlier death, resignation, or removal from office, as follows: Nominees Votes For Votes Withheld Broker Non-Votes Brenton L. Saunders 64,713,062 7,259,415 21,434,437 Pedro Malha 70,933,549 1,038,928 21,434,437 E. Scott Beattie 61,017,737 10,954,740 21,434,437 Stephen J. Fanning 68,732,826 3,239,651 21,434,437 Michelle Kerrick 70,684,772 1,287,705 21,434,437 Brian Miller 56,555,107 15,417,370 21,434,437 Doug Schillinger 61,107,166 10,865,311 21,434,437 Sachin Shridharani, M.D. 71,317,162 655,315 21,434,437 Kenneth Tripp 71,078,056 894,421 21,434,437

The Company’s stockholders approved, on an advisory, non-binding basis, the compensation paid by the Company to its named executive officers as disclosed in the Proxy Statement, as follows: Votes For Votes Against Abstentions Broker Non-Votes 58,604,735 12,346,541 1,021,201 21,434,437